acetaminophen has been researched along with dabrafenib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XX; Chen, Y; Ding, J; Feng, JM; Li, JX; Li, XH; Miao, ZH; Shen, YY; Su, Y; Wang, Y; Xiong, B; Yang, CH | 1 |
| Azer, M; Clements, A; Haydu, LE; Kefford, RF; Lee, CI; Long, GV; Menzies, AM | 1 |
1 trial(s) available for acetaminophen and dabrafenib
| Article | Year |
|---|---|
Features and management of pyrexia with combined dabrafenib and trametinib in metastatic melanoma.
Topics: Acetaminophen; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fever; Humans; Imidazoles; Male; Melanoma; Middle Aged; Oximes; Pyridones; Pyrimidinones; Retrospective Studies; Temperature; Treatment Outcome | 2014 |
1 other study(ies) available for acetaminophen and dabrafenib
| Article | Year |
|---|---|
The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury.
Topics: Acetaminophen; Amino Acid Substitution; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Humans; Imidazoles; Male; Mice; Mutation, Missense; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Receptor-Interacting Protein Serine-Threonine Kinases; U937 Cells | 2014 |